Metal-organic frameworks as protective matrices for peptide therapeutics

Area of Science:

• Pharmaceutical Science
• Materials Science
• Biotechnology

Background:

• Peptide drugs are crucial for disease treatment but suffer from poor chemical and physical stability.
• Instability necessitates cold storage, which is often inaccessible, limiting peptide drug accessibility.
• Developing ambient-stable peptide formulations is a significant challenge in pharmaceutical development.

Purpose of the Study:

• To develop an efficient and facile strategy for enhancing the stability of peptide drugs.
• To protect peptide drugs against harsh environmental conditions, including temperature fluctuations and enzymatic degradation.
• To provide a viable alternative for storing and delivering biopharmaceuticals under ambient conditions.

Main Methods:

• Biomineralization of metal-organic frameworks (MOFs) around peptide drugs.
• Encapsulation of peptide drugs within MOF structures.
• Testing the stability and biological activity of released peptides after exposure to stress conditions.

Main Results:

• Peptide drugs encapsulated in MOFs demonstrated remarkable stability.
• Released peptides retained their structural integrity and full biological activity after exposure to high temperatures.
• The MOF-protected peptides also withstood repeated freeze-thaw cycles and enzymatic degradation.

Conclusions:

• Biomineralization using MOFs offers an effective strategy to enhance peptide drug stability.
• This approach provides robust protection against various environmental stressors, enabling storage under ambient conditions.
• The developed method presents a promising alternative for the formulation and storage of peptide-based biopharmaceuticals.